Cargando…

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma

Detalles Bibliográficos
Autor principal:	Eso, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925291/ https://www.ncbi.nlm.nih.gov/pubmed/32963171 http://dx.doi.org/10.2169/internalmedicine.5923-20

Ejemplares similares

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
por: Nakano, Shigeharu, et al.
Publicado: (2020)

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
por: Campani, Claudia, et al.
Publicado: (2020)

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis
por: Kim, Jin-Wook
Publicado: (2010)

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
por: Oe, Natsumi, et al.
Publicado: (2022)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
por: Mossenta, Monica, et al.
Publicado: (2019)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2021)

Development of conversion therapy for advanced hepatocellular carcinoma
por: Matsuki, Ryota, et al.
Publicado: (2023)

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
por: Moawad, Ahmed W, et al.
Publicado: (2020)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Evolution of systemic therapy for advanced-stage hepatocellular carcinoma
por: Hur, Moon Haeng, et al.
Publicado: (2022)

Recent Advances in Bioinformatics Reveal the Molecular Heterogeneity of Hepatocellular Carcinoma
Publicado: (2014)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study
por: Fodor, Decebal, et al.
Publicado: (2019)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis
por: Yoshiji, Satoshi, et al.
Publicado: (2018)

Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
por: Khare, Tripti, et al.
Publicado: (2017)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
por: Kim, Beom Kyung
Publicado: (2023)

Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2019)

Targeting the Metabolic Vulnerability of ARID1A-Deficient Hepatocellular Carcinoma
por: Chan, For-Fan, et al.
Publicado: (2022)

Advancing prognostic precision in hepatocellular carcinoma: a paradigm shift towards machine learning
por: Milana, Flavio, et al.
Publicado: (2023)

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016)

Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
por: Li, Ming, et al.
Publicado: (2017)

Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2013)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Angiogenesis
por: Zhao, Qiang, et al.
Publicado: (2015)

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2015)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future
por: Woo, Hyun Young, et al.
Publicado: (2020)

Tivozanib in advanced inoperable hepatocellular carcinoma: considerations for patients with liver cirrhosis
por: Oh, Hyunwoo, et al.
Publicado: (2020)

Sorafenib plus doxorubicin in advanced hepatocellular carcinoma patients: hope or hype?
por: Shing, Kit, et al.
Publicado: (2020)

Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
por: Sanz-Cameno, Paloma, et al.
Publicado: (2010)

Fucoidan Inhibits the Growth of Hepatocellular Carcinoma Independent of Angiogenesis
por: Zhu, Cong, et al.
Publicado: (2013)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang, Jianlong, et al.
Publicado: (2021)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
por: Yao, Changyu, et al.
Publicado: (2023)

Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma
por: Eso, Yuji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ccag94hcl7ftl36hpo016cmqk